PRESS

Cold Agglutinin Disease in the Setting of Pancreatic Adenocarcinoma

Phan Hong; Motiani Vanita; Bannon Susan

    Autoimmune Hemolytic Anemia (AIHA) is caused by antibody-mediated destruction of red blood cells. There are two broad categories of AIHA: warm and cold, both categorized by the thermal reactivity of the autoantibodies [1]. Cold AIHA, or Cold Agglutinin Disease (CAD), occurs at temperatures below normal body temperature and primarily involves IgM antibodies.


Massive Hemorrhagic Ascites at Stage 1A Juvenile Granulosa Cell Tumor in a 5 Years Child: A Case Report and Review of the Literature

Okbu Frezgi*; Dawit Sereke; Rami Yassin; Mahmud Mohammed; Berhe Tesfai

    Juvenile granulosa cell tumor is a sex cordstromal tumor, which is the leading cause of precocious puberty. Massive hemorrhagic ascites at early stage was rarely reported. Here we report a rare case of Stage 1A juvenile granulosa cell tumor with massive hemorrhagic ascites in a 5 years old Eritrean child.


Primary Malignant Melanoma of the Lung with Unusual ARID1A K1010R Somatic Mutation: Exploring the Highly Variable Genomic Phenotype among Melanomas

Rebecca C Olsen*; Bryan Clippinger; Bennet Chun; Jacob Sanchez; Favia Dubyk; Abhinav Mittal

    Melanoma has the highest prevalence of somatic mutations among all malignancies [1-5]. Primary lung melanoma is rare, representing 0.01% of all primary lung tumors [6-11]. We present a case with no common melanoma-associated mutations but a mutation in the ARID1A K1010R gene, highlighting a novel mutation that may guide future research and therapies.


Carcinoma ex Pleomorphic Adenoma of the Parotid Gland with Metastasis to the Lung: Case Report and Review of the Literature

Mozaffar Aznab*; Mohammad Gharib salehi

    Carcinoma ex pleomorphic adenoma) CA-ex-PA) is an uncommon tumor of the salivary glands that may present with metastasis. This article aimed to evaluate the response to treatment of a patient with CA-ex-PA and lung metastasis to combination chemotherapy.


Case of Hormone-Positive Breast Cancer Recurrence after 41 Years, with Literature Review on Breast Cancer Management Evolution

Stuti M Trivedi*; Rene R Rubin

   Breast cancer has the highest chances of recurring within the first five years after initial treatment. Recurrence beyond this period, known as late recurrence, which is more common in women with high lymph node involvement, large tumor size, triple-negative tumors, and estrogen receptor-positive tumors. We present


MedDocs Publishers

We always work towards offering the best to you. For any queries, please feel free to get in touch with us. Also you may post your valuable feedback after reading our journals, ebooks and after visiting our conferences.